Your session is about to expire
← Back to Search
Behavioral Intervention
THRIVE 365 for Depression (OTD Trial)
N/A
Waitlist Available
Led By Devin English, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights
OTD Trial Summary
This trial tests a novel intervention to help Black sexual minority men (BSMM) improve their HIV & mental health, build community, access support, & get resources. It uses a 14-day daily diary to measure its effects.
Eligible Conditions
- Emotion Regulation
- Medication Adherence
- Depression
- Anxiety
OTD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Antiretroviral (ART) Medication Use
Anxiety Symptoms
Depressive Symptoms
+1 moreSecondary outcome measures
Coping
OTD Trial Design
1Treatment groups
Experimental Treatment
Group I: iTHRIVE 365Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iTHRIVE 365
2021
N/A
~40
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,784 Previous Clinical Trials
2,689,241 Total Patients Enrolled
3 Trials studying Emotion Regulation
376 Patients Enrolled for Emotion Regulation
Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,198 Total Patients Enrolled
2 Trials studying Emotion Regulation
190 Patients Enrolled for Emotion Regulation
THRIVE Social Services Inc. (THRIVE SS)UNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have unstable or severe mental health symptoms that could become worse if you participate in the study.You have feelings of attraction towards men or have engaged in sexual activities with men.
Research Study Groups:
This trial has the following groups:- Group 1: iTHRIVE 365
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger